Haemonetics Corporation sold its whole blood assets in the Blood Center business to GVS, S.p.A. for up to $67.8 million, including $45.3 million upfront and up to $22.5 million based on future sales growth over three years.
AI Assistant
HAEMONETICS CORP
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.